CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.9654
-0.0746 (-7.17%)
At close: Jul 2, 2026, 4:00 PM EDT
0.9390
-0.0264 (-2.73%)
After-hours: Jul 2, 2026, 7:46 PM EDT
CalciMedica Employees
CalciMedica had 16 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
16
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,221,500
Market Cap
15.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 16 | 0 | - |
| Dec 31, 2025 | 16 | 2 | 14.29% |
| Dec 31, 2024 | 14 | 2 | 16.67% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| Moleculin Biotech | 17 |
| Werewolf Therapeutics | 14 |
| BioVie | 13 |
| Cocrystal Pharma | 10 |
| Tempest Therapeutics | 5 |
CALC News
- 10 days ago - CalciMedica announces $49M private placement - TheFly
- 10 days ago - CalciMedica announces FDA review of protocol amendment for Kourage trial - TheFly
- 10 days ago - CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program - PRNewsWire
- 10 days ago - CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data - PRNewsWire
- 7 weeks ago - CalciMedica Quarterly report: Q1 2026 - Filings
- 7 weeks ago - CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 4 months ago - CalciMedica price target lowered to $10 from $20 at Oppenheimer - TheFly
- 4 months ago - CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - PRNewsWire